Inflammatory Bowel Diseases
Mostrando 1-12 de 92 artigos, teses e dissertações.
-
1. Systematic review on fecal calprotectin in cystic fibrosis
Abstract Objectives: Fecal calprotectin is an inflammatory marker used for monitoring intestinal diseases. It has been studied as a marker of intestinal inflammation in cystic fibrosis (CF), a multi-systemic genetic disease caused by alterations to the CFTR gene. Manifestations of the disease favor a systemic inflammation not limited to the respiratory trac
Jornal de Pediatria. Publicado em: 2023
-
2. HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CROHN’S DISEASE: POSITION PAPER FROM THE TRANSPLANTATION COMMITTEE OF THE BRAZILIAN GROUP FOR THE STUDY OF INFLAMMATORY BOWEL DISEASES (GEDIIB)
RESUMO A doença de Crohn (DC) é uma doença inflamatória intestinal (DII) recidivante recorrente que pode afetar qualquer parte do sistema digestivo. É doença heterogênea e possui múltiplos fatores que contribuem para uma resposta imune anormal aos microrganismos intestinais. O tratamento baseia-se no uso de anti-inflamatórios, corticosteroides e imu
Arquivos de Gastroenterologia. Publicado em: 2022
-
3. INCIDENCE, PREVALENCE, AND EPIDEMIOLOGICAL CHARACTERISTICS OF INFLAMMATORY BOWEL DISEASES IN THE STATE OF PARANÁ IN SOUTHERN BRAZIL
RESUMO Contexto: A epidemiologia das doenças inflamatórias intestinais (DII) varia em diferentes regiões do Brasil. Este estudo transversal avaliou as características epidemiológicas da DII no estado do Paraná no sul do Brasil. Métodos: Foram incluídos pacientes com DII (n=6,748) selecionados de 11.468.818 habitantes no estado do Paraná. Todos os
Arquivos de Gastroenterologia. Publicado em: 2022
-
4. Epidemiological profile of inflammatory bowel disease in Caxias do Sul, Brazil: a cross-sectional study
ABSTRACT BACKGROUND: Inflammatory bowel diseases affect mostly young patients and have a huge impact on their quality of life and growing treatment costs. Currently, there are few Brazilian studies concerning their epidemiological profile. OBJECTIVE: The aim of this study was to describe the regional clinical and epidemiological profile of these pathologic
Sao Paulo Med. J.. Publicado em: 2020-12
-
5. Spitz nevus and infliximab: association or coincidence?,
Abstract Biological therapies, including anti-TNF agents, are important in the treatment of various chronic inflammatory diseases, including psoriasis, rheumatoid arthritis or inflammatory bowel disease. The increased use of these drugs translates into an increasing awareness of its adverse effects, which include malignancy. In this paper, we describe the ca
An. Bras. Dermatol.. Publicado em: 2020-10
-
6. Inflammatory Bowel Diseases and diet: an integrative review
RESUMO OBJETIVO: Reunir evidências científicas sobre o papel da dieta nas doenças inflamatórias intestinais. MÉTODOS: Revisão integrativa com estudos publicados nos últimos 10 anos em periódicos nacionais e internacionais. Foram incluídos estudos originais desenvolvidos com seres humanos adultos com idade ≥18anos e excluídos artigos publicados
Rev. Assoc. Med. Bras.. Publicado em: 2020-10
-
7. VEDOLIZUMAB IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES: A BRAZILIAN OBSERVATIONAL MULTICENTRIC STUDY
RESUMO CONTEXTO: Há escassez de dados sobre a eficácia e segurança do vedolizumabe nas doenças inflamatórias intestinais na América Latina. OBJETIVO: Descrever a primeira experiência observacional de mundo real com vedolizumabe em pacientes latino-americanos com doenças inflamatórias intestinais. MÉTODOS: Estudo retrospectivo multicêntrico o
Arq. Gastroenterol.. Publicado em: 30/09/2019
-
8. BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES
RESUMO CONTEXTO: A introdução dos agentes anti-TNF representou um marco no tratamento da doença de Crohn (DC) e da recocolite ulcerativa (RCU), com maior eficácia e segurança quando comparado ao tratamento convencional. No entanto, ainda existem desafios significativos na América Latina para facilitar o acesso dos agentes biológicos a médicos e pac
Arq. Gastroenterol.. Publicado em: 30/09/2019
-
9. Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases
Abstract Background: In Brazil, we are facing an alarming epidemic scenario of Yellow fever (YF), which is reaching the most populous areas of the country in unvaccinated people. Vaccination is the only effective tool to prevent YF. In special situations, such as patients with chronic immune-mediated inflammatory diseases (CIMID), undergoing immunosuppressi
Adv. rheumatol.. Publicado em: 29/07/2019
-
10. Gut: Key Element on Immune System Regulation
Abstract The gut is the main organ that mediates the contact between antigens with our organism, controlling the immune response against environmental factors, such as microbiota and food. Innate lymphoid cells participate in the gut-associated lymphoid tissue (GALT) maturation during the prenatal and early postnatal periods. After birth, breast milk provide
Braz. arch. biol. technol.. Publicado em: 13/06/2019
-
11. Linear growth and bone metabolism in pediatric patients with inflammatory bowel disease
Resumo Objetivo: Revisar a fisiopatologia e os métodos de avaliação do crescimento linear e densidade mineral óssea em crianças e adolescentes com diagnóstico de doença inflamatória intestinal. Fontes dos dados: Revisão narrativa a partir de pesquisa nas bases de dados PubMed e Scopus por meio de busca ativa dos termos inflammatory bowel disease,
J. Pediatr. (Rio J.). Publicado em: 18/04/2019
-
12. Paraneoplastic Sweet’s syndrome
Abstract: Sweet’s syndrome is a rare dermatosis with little-known pathogenesis, associated with some clinical conditions such as infections, autoimmune diseases, inflammatory bowel diseases, vaccination, medications and neoplasms. Hematologic malignancies are the diseases most related to paraneoplastic Sweet’s syndrome, but this clinical entity can also
An. Bras. Dermatol.. Publicado em: 2018-08